Cantor Fitzgerald Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
497,083
+4,674
+0.9% +$122K 0.81% 48
2026
Q1
$13.8M Buy
492,409
+19,433
+4% +$517K 1.02% 38
2025
Q4
$11.8M Sell
472,976
-74,208
-14% -$1.87M 0.87% 41
2025
Q3
$13.9M Buy
547,184
+25,090
+5% +$619K 0.95% 38
2025
Q2
$12.7M Buy
522,094
+9,592
+2% +$224K 0.89% 43
2025
Q1
$13M Sell
512,502
-14,500
-3% -$379K 0.95% 46
2024
Q4
$14M Sell
527,002
-25,873
-5% -$702K 0.97% 47
2024
Q3
$16M Buy
552,875
+3,347
+0.6% +$97.6K 1.09% 38
2024
Q2
$15.4M Sell
549,528
-12,275
-2% -$338K 1.18% 34
2024
Q1
$15.6M Buy
561,803
+277
+0% +$7.69K 1.16% 34
2023
Q4
$16.2M Buy
+561,526
New +$17M 1.25% 31
2022
Q1
$25.3M Buy
489,145
+165,174
+51% +$8.57M 1.13% 26
2021
Q4
$19.1M Buy
323,971
+1,039
+0.3% +$51.5K 1.16% 17
2021
Q3
$13.9M Buy
322,932
+2,049
+0.6% +$90.8K 1.03% 24
2021
Q2
$12.6M Buy
+320,883
New +$12.5M 0.92% 28

Other funds holding PFE

Cantor Fitzgerald Investment Advisors's PFE Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors increased its Pfizer (PFE) stake by 0.95% in Q2 2026, buying an estimated $122K and bringing the position to 497,083 shares worth $12M. The position accounts for 0.81% of the portfolio, ranked #48.

Cantor Fitzgerald Investment Advisors first reported a position in PFE in Q2 2021 and has held it in 15 quarters since. The position peaked at $25.3M in Q1 2022. 1,267 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cantor Fitzgerald Investment Advisors held 497,083 shares of Pfizer worth $12M as of Q2 2026.
  • Cantor Fitzgerald Investment Advisors bought 4,674 Pfizer shares in Q2 2026, an estimated $122K.
  • Pfizer made up 0.81% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #48 holding.
  • Cantor Fitzgerald Investment Advisors first reported a position in Pfizer in Q2 2021 and has held it in 15 quarters since.
  • Cantor Fitzgerald Investment Advisors's Pfizer position peaked at $25.3M in Q1 2022.
  • 1,267 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.